SAB Biotherapeutics, Inc. SABS
3.07 USD -0.03 (-0.97%)
At closeNov 10, 2026, 4:01 PM EST
3.07 0.00 0.00%
After hours · Nov 10, 4:01 PM ET
2.96 Day range 3.14
2.44 52-week range 5.15
- YTD
- -17.91%
- 1 year
- -4.06%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -48.95M | -42.91M | -38.08M | -28.92M | -13.39M | |
| 13.27M | -34.11M | -42.19M | -18.74M | -17.14M | |
| -0.79 | -3.68 | -7.64 | -4.31 | -6.30 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.50M | 8.90M | 56.57M | 15.05M | 39.55M | |
| 172.81M | 44.20M | 83.94M | 50.90M | 81.14M | |
| 21.32M | 18.23M | 26.64M | 19.85M | 42.59M | |
| 5.95M | 4.67M | 5.91M | 5.93M | 8.52M | |
| 151.50M | 25.97M | 57.30M | 31.06M | 38.55M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -44.78M | -34.29M | -25.12M | -23.46M | 1.99M | |
| -121.71M | -11.96M | -152.70K | -2.09M | -10.94M | |
| 168.30M | -1.17M | 66.77M | 1.05M | 35.89M | |
| -932.66K | -337.26K | -152.70K | -2.09M | -10.94M | |
| 1.60M | -47.67M | 41.52M | -24.50M | 26.93M |